Gary Coward, Senior Director, Peri-Approval Clinical Excellence,
Clinical Research Services
-- Biosimilars: What Should the Next Steps Be? -- Session Co-Chair: Cecil
Nick, Principal Consultant, PAREXEL Consulting
-- Cosmeceuticals: Marketing Topical Products without Making Licensable
Medicinal Claims in Europe -- Peter Lassoff, Vice President, PAREXEL
For more than 25 years, clients have relied on PAREXEL to provide integrated clinical development, regulatory affairs consulting, and commercialization services, as well as to offer technologies that expedite time-to-market. Attendees at the DIA EuroMeeting can visit PAREXEL's Booth 179 in the exhibit hall to discuss these areas or to view a demonstration of the industry-leading Clinical Trial Management System IMPACT(R) software, provided by PAREXEL's subsidiary, Perceptive Informatics.
DIA's 20th Annual EuroMeeting is global in scope, attracting more than 3,000 attendees. This meeting brings together professionals from the biopharmaceutical industry, contract service organizations, academic research centers, and regulatory agencies. With more than 100 sessions and 11 themes, and more than 350 speakers, the annual event covers a variety of cross- disciplinary topics.
For more information about PAREXEL visit http://www.PAREXEL.com or Booth 179 at the DIA EuroMeeting.
About PAREXEL International
PAREXEL International Corporation is a leading global
bio/pharmaceutical services organization, providing a broad range of
knowledge-based contract research, medical communications and consulting
services to the worldwide pharmaceutical, biotechnology and medical device
industries. Committed to providing solutions that expedite time-to-market
and peak-market penetration, PAREXEL
|SOURCE PAREXEL International Corporation|
Copyright©2008 PR Newswire.
All rights reserved